http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CR-20170182-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
filingDate 2015-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_141cf82bc358b7f5f09efab58a5f34fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e07af0f0ccfa14c86119101971b9f48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1e95c376fd0418f3d3023c6b5a31049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee76ed2730a8ca0330f58923a6291925
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96b1930f209614fd23fe6a4d9e8c18e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d01101713ec8ee1ff365a04635114542
publicationDate 2017-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CR-20170182-A
titleOfInvention DERIVATIVES OF TIENO [2,3-C] PIRROL-4-ONA AS ERK INHIBITORS
abstract The present invention relates to thieno [2,3-c] pyrrol-4-one compounds that inhibit the activity of regulated extracellular signal kinase (ERK) and may be useful in the treatment of cancer.
priorityDate 2014-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121408901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414782279

Total number of triples: 33.